Bacteriophages as a Potential 360-Degree Pathogen Control Strategy
Abstract
:1. Introduction
2. Phage-Based Therapy
3. Food Safety-Related Applications of Phages: From Farms to Industries
4. Bacteriophage Application in Agriculture and Aquaculture
5. Bacteriophages for Wastewater Plant Treatment
6. Bacteriophages as Environmental Sanitizers in Hospitals
7. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Rice, L.B. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE. J. Infect. Dis. 2008, 197, 1079–1081. [Google Scholar] [CrossRef] [PubMed]
- WHO. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics; WHO: Geneva, Switzerland, 2017. [Google Scholar]
- O’Neill, J. Antimicrobial Resistance: Tackling a crisis for the health and wealth of nations. Available online: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf (accessed on 22 November 2020).
- Jamal, M.; Bukhari, S.; Andleeb, S.; Ali, M.; Raza, S.; Nawaz, M.A.; Hussain, T.; Rahman, S.U.; Shah, S.S.A. Bacteriophages: An overview of the control strategies against multiple bacterial infections in different fields. J. Basic Microbiol. 2019, 59, 123–133. [Google Scholar] [CrossRef] [PubMed]
- Hendrix, R.W. Bacteriophages: Evolution of the majority. Theor. Popul. Biol. 2002, 61, 471–480. [Google Scholar] [CrossRef] [PubMed]
- Tartera, C.; Jofre, J. Bacteriophages active against Bacteroides fragilis in sewage-polluted waters. Appl. Environ. Microbiol. 1987, 53, 1632–1637. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kumari, S.; Harjai, K.; Chhibber, S. Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples. Folia Microbiol. 2010, 55, 221–227. [Google Scholar] [CrossRef]
- Gantzer, C.; Henny, J.; Schwartzbrod, L. Bacteroides fragilis and Escherichia coli bacteriophages in human faeces. Int. J. Hyg. Environ. Health 2002, 205, 325–328. [Google Scholar] [CrossRef]
- Bachrach, G.; Leizerovici-Zigmond, M.; Zlotkin, A.; Naor, R.; Steinberg, D. Bacteriophage isolation from human saliva. Lett. Appl. Microbiol. 2003, 36, 50–53. [Google Scholar] [CrossRef] [PubMed]
- Sulakvelidze, A.; Alavidze, Z.; Morris, J.G., Jr. Bacteriophage therapy. Antimicrob. Agents Chemother. 2001, 45, 649–659. [Google Scholar] [CrossRef] [Green Version]
- Ackermann, H.-W. Tailed Bacteriophages: The Order Caudovirales. In Advances in Virus Research; Maramorosch, K., Murphy, F.A., Shatkin, A.J., Eds.; Academic Press: Quebec, QC, Canada, 1998; Volume 51, pp. 135–201. [Google Scholar]
- Abedon, S.T. Advances in Molecular and Cellular Microbiology; Abedon, S.T., Ed.; Cambridge University Press: Cambridge, MA, USA; New York, NY, USA, 2008; Volume 15. [Google Scholar]
- Harada, L.K.; Silva, E.C.; Campos, W.F.; Del Fiol, F.S.; Vila, M.; Dabrowska, K.; Krylov, V.N.; Balcao, V.M. Biotechnological applications of bacteriophages: State of the art. Microbiol. Res. 2018, 212, 38–58. [Google Scholar] [CrossRef]
- Weinbauer, M.G. Ecology of prokaryotic viruses. FEMS Microbiol. Rev. 2004, 28, 127–181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kazmierczak, Z.; Gorski, A.; Dabrowska, K. Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses 2014, 6, 2551–2570. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mimmi, S.; Maisano, D.; Quinto, I.; Iaccino, E. Phage Display: An Overview in Context to Drug Discovery. Trends Pharmacol. Sci. 2019, 40, 87–91. [Google Scholar] [CrossRef] [PubMed]
- Mimmi, S.; Maisano, D.; Nistico, N.; Vecchio, E.; Chiurazzi, F.; Ferrara, K.; Iannalfo, M.; D’Ambrosio, A.; Fiume, G.; Iaccino, E.; et al. Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors. Leukemia 2020. [Google Scholar] [CrossRef] [PubMed]
- Pelechas, E.; Voulgari, P.V.; Drosos, A.A. Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert Opin. Drug Discov. 2020, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Kakasis, A.; Panitsa, G. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review. Int. J. Antimicrob. Agents 2019, 53, 16–21. [Google Scholar] [CrossRef] [PubMed]
- Chanishvili, N. Phage therapy—History from Twort and d’Herelle through Soviet experience to current approaches. Adv. Virus Res. 2012, 83, 3–40. [Google Scholar] [CrossRef]
- Principi, N.; Silvestri, E.; Esposito, S. Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections. Front Pharmacol. 2019, 10. [Google Scholar] [CrossRef] [Green Version]
- Maciejewska, B.; Olszak, T.; Drulis-Kawa, Z. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: An ambitious and also a realistic application? Appl. Microbiol. Biotechnol. 2018, 102, 2563–2581. [Google Scholar] [CrossRef] [Green Version]
- Chan, B.K.; Abedon, S.T.; Loc-Carrillo, C. Phage cocktails and the future of phage therapy. Future Microbiol. 2013, 8, 769–783. [Google Scholar] [CrossRef]
- Rose, T.; Verbeken, G.; Vos, D.D.; Merabishvili, M.; Vaneechoutte, M.; Lavigne, R.; Jennes, S.; Zizi, M.; Pirnay, J.P. Experimental phage therapy of burn wound infection: Difficult first steps. Int. J. Burns Trauma 2014, 4, 66–73. [Google Scholar]
- Rhoads, D.D.; Wolcott, R.D.; Kuskowski, M.A.; Wolcott, B.M.; Ward, L.S.; Sulakvelidze, A. Bacteriophage therapy of venous leg ulcers in humans: Results of a phase I safety trial. J. Wound Care 2009, 18, 237–238. [Google Scholar] [CrossRef] [PubMed]
- Wright, A.; Hawkins, C.H.; Anggard, E.E.; Harper, D.R. A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; A preliminary report of efficacy. Clin. Otolaryngol. 2009, 34, 349–357. [Google Scholar] [CrossRef] [PubMed]
- PhagoBurn: Evaluation of Phage Therapy for the Treatment of Burn Wound Infections. Available online: http://www.phagoburn.eu/about-phagoburn.html (accessed on 22 October 2020).
- LaFee, S.; Buschman, H. With OK From FDA, UC San Diego Researchers Prepare to Launch Novel Phage Study. Clinical Trial Using Intravenous Viruses to Kill Resistant Bacteria Would be First in Nation. Available online: https://health.ucsd.edu/news/releases/Pages/2019-01-08-FDA-okays-uc-san-diego-to-launch-novel-phage-study.aspx (accessed on 25 June 2020).
- Bacteriophage.news. FDA Allows Phage Therapy for COVID19 Patients. Available online: https://www.bacteriophage.news/fda-phage-therapy-for-covid19-patients/ (accessed on 26 November 2020).
- Gutierrez, D.; Fernandez, L.; Rodriguez, A.; Garcia, P. Role of Bacteriophages in the Implementation of a Sustainable Dairy Chain. Front Microbiol. 2019, 10, 12. [Google Scholar] [CrossRef] [PubMed]
- Fan, J.; Zeng, Z.; Mai, K.; Yang, Y.; Feng, J.; Bai, Y.; Sun, B.; Xie, Q.; Tong, Y.; Ma, J. Preliminary treatment of bovine mastitis caused by Staphylococcus aureus, with trx-SA1, recombinant endolysin of S. aureus bacteriophage IME-SA1. Vet. Microbiol. 2016, 191, 65–71. [Google Scholar] [CrossRef] [PubMed]
- Da Silva Duarte, V.; Dias, R.S.; Kropinski, A.M.; Campanaro, S.; Treu, L.; Siqueira, C.; Vieira, M.S.; da Silva Paes, I.; Santana, G.R.; Martins, F.; et al. Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows. Sci. Rep. 2018, 8, 6845. [Google Scholar] [CrossRef]
- Breyne, K.; Honaker, R.W.; Hobbs, Z.; Richter, M.; Zaczek, M.; Spangler, T.; Steenbrugge, J.; Lu, R.; Kinkhabwala, A.; Marchon, B.; et al. Efficacy and Safety of a Bovine-Associated Staphylococcus aureus Phage Cocktail in a Murine Model of Mastitis. Front Microbiol. 2017, 8, 2348. [Google Scholar] [CrossRef]
- Abdelhaseib, M.U.; Singh, A.K.; Bhunia, A.K. Simultaneous detection of Salmonella enterica, Escherichia coli and Listeria monocytogenes in food using a light scattering sensor. J. Appl. Microbiol. 2019, 126, 1496–1507. [Google Scholar] [CrossRef]
- Batinovic, S.; Wassef, F.; Knowler, S.A.; Rice, D.T.F.; Stanton, C.R.; Rose, J.; Tucci, J.; Nittami, T.; Vinh, A.; Drummond, G.R.; et al. Bacteriophages in Natural and Artificial Environments. Pathogens 2019, 8. [Google Scholar] [CrossRef] [Green Version]
- Moye, Z.D.; Woolston, J.; Sulakvelidze, A. Bacteriophage Applications for Food Production and Processing. Viruses 2018, 10, 205. [Google Scholar] [CrossRef] [Green Version]
- Abuladze, T.; Li, M.; Menetrez, M.Y.; Dean, T.; Senecal, A.; Sulakvelidze, A. Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. Appl. Environ. Microbiol. 2008, 74, 6230–6238. [Google Scholar] [CrossRef] [Green Version]
- Leverentz, B.; Conway, W.S.; Camp, M.J.; Janisiewicz, W.J.; Abuladze, T.; Yang, M.; Saftner, R.; Sulakvelidze, A. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl. Environ. Microbiol. 2003, 69, 4519–4526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- O’Flynn, G.; Ross, R.P.; Fitzgerald, G.F.; Coffey, A. Evaluation of a cocktail of three bacteriophages for biocontrol of Escherichia coli O157:H7. Appl. Environ. Microbiol. 2004, 70, 3417–3424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Goode, D.; Allen, V.M.; Barrow, P.A. Reduction of experimental Salmonella and Campylobacter contamination of chicken skin by application of lytic bacteriophages. Appl. Environ. Microbiol. 2003, 69, 5032–5036. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sharma, M.; Patel, J.R.; Conway, W.S.; Ferguson, S.; Sulakvelidze, A. Effectiveness of bacteriophages in reducing Escherichia coli O157:H7 on fresh-cut cantaloupes and lettucet. J. Food Prot. 2009, 72, 1481–1485. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guenther, S.; Huwyler, D.; Richard, S.; Loessner, M.J. Virulent bacteriophage for efficient biocontrol of Listeria monocytogenes in ready-to-eat foods. Appl. Environ. Microbiol. 2009, 75, 93–100. [Google Scholar] [CrossRef] [Green Version]
- Zhang, H.; Wang, R.; Bao, H. Phage inactivation of foodborne Shigella on ready-to-eat spiced chicken. Poult. Sci. 2013, 92, 211–217. [Google Scholar] [CrossRef] [PubMed]
- Sharma, M. Lytic bacteriophages: Potential interventions against enteric bacterial pathogens on produce. Bacteriophage 2013, 3, e25518. [Google Scholar] [CrossRef]
- FDA. Listeria-Specific Bacteriophage Preparation. Food Additives Permitted for Direct Addition to Food for Human Consumption; Federal Register: Silver Spring, MD, USA, 2006; pp. 47729–47732. [Google Scholar]
- Latorre, A.A.; Van Kessel, J.S.; Karns, J.S.; Zurakowski, M.J.; Pradhan, A.K.; Boor, K.J.; Jayarao, B.M.; Houser, B.A.; Daugherty, C.S.; Schukken, Y.H. Biofilm in milking equipment on a dairy farm as a potential source of bulk tank milk contamination with Listeria monocytogenes. J. Dairy Sci. 2010, 93, 2792–2802. [Google Scholar] [CrossRef] [PubMed]
- Doyle, S.; Meade, E.; Fowley, C.; Garvey, M. A Comprehensive Review of Current Environmental Pollutants of Pharmaceutical, Agricultural and Industrial Origin. Eur. J. Exp. Biol. 2020, 10, 5. [Google Scholar] [CrossRef]
- Vandini, A.; Temmerman, R.; Frabetti, A.; Caselli, E.; Antonioli, P.; Balboni, P.G.; Platano, D.; Branchini, A.; Mazzacane, S. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS ONE 2014, 9, e108598. [Google Scholar] [CrossRef] [Green Version]
- Wand, M.E.; Bock, L.J.; Bonney, L.C.; Sutton, J.M. Mechanisms of Increased Resistance to Chlorhexidine and Cross-Resistance to Colistin following Exposure of Klebsiella pneumoniae Clinical Isolates to Chlorhexidine. Antimicrob. Agents Chemother. 2017, 61. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tomat, D.; Quiberoni, A.; Mercanti, D.; Balagué, C. Hard surfaces decontamination of enteropathogenic and Shiga toxin-producing Escherichia coli using bacteriophages. Food Res. Int. 2014, 57, 123–129. [Google Scholar] [CrossRef]
- Wang, C.; Hang, H.; Zhou, S.; Niu, Y.D.; Du, H.; Stanford, K.; McAllister, T.A. Bacteriophage biocontrol of Shiga toxigenic Escherichia coli (STEC) O145 biofilms on stainless steel reduces the contamination of beef. Food Microbiol. 2020, 92, 103572. [Google Scholar] [CrossRef] [PubMed]
- Rodríguez-Melcón, C.; Capita, R.; García-Fernández, C.; Alonso-Calleja, C. Effects of Bacteriophage P100 at Different Concentrations on the Structural Parameters of Listeria monocytogenes Biofilms. J. Food Prot. 2018, 81, 2040–2044. [Google Scholar] [CrossRef]
- Islam, M.S.; Zhou, Y.; Liang, L.; Nime, I.; Liu, K.; Yan, T.; Wang, X.; Li, J. Application of a Phage Cocktail for Control of Salmonella in Foods and Reducing Biofilms. Viruses 2019, 11. [Google Scholar] [CrossRef] [Green Version]
- Woolston, J.; Parks, A.R.; Abuladze, T.; Anderson, B.; Li, M.; Carter, C.; Hanna, L.F.; Heyse, S.; Charbonneau, D.; Sulakvelidze, A. Bacteriophages lytic for Salmonella rapidly reduce Salmonella contamination on glass and stainless steel surfaces. Bacteriophage 2013, 3, e25697. [Google Scholar] [CrossRef] [Green Version]
- Iacumin, L.; Manzano, M.; Comi, G. Phage Inactivation of Listeria monocytogenes on San Daniele Dry-Cured Ham and Elimination of Biofilms from Equipment and Working Environments. Microorganisms 2016, 4. [Google Scholar] [CrossRef] [Green Version]
- Gutierrez, D.; Rodriguez-Rubio, L.; Martinez, B.; Rodriguez, A.; Garcia, P. Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry. Front Microbiol. 2016, 7, 825. [Google Scholar] [CrossRef]
- Savary, S.; Willocquet, L.; Pethybridge, S.J.; Esker, P.; McRoberts, N.; Nelson, A. The global burden of pathogens and pests on major food crops. Nat. Ecol. Evol. 2019, 3, 430–439. [Google Scholar] [CrossRef]
- Rombouts, S.; Volckaert, A.; Venneman, S.; Declercq, B.; Vandenheuvel, D.; Allonsius, C.N.; Van Malderghem, C.; Jang, H.B.; Briers, Y.; Noben, J.P.; et al. Characterization of Novel Bacteriophages for Biocontrol of Bacterial Blight in Leek Caused by Pseudomonas syringae pv. porri. Front. Microbiol. 2016, 7, 279. [Google Scholar] [CrossRef] [Green Version]
- Wei, C.; Liu, J.; Maina, A.N.; Mwaura, F.B.; Yu, J.; Yan, C.; Zhang, R.; Wei, H. Developing a bacteriophage cocktail for biocontrol of potato bacterial wilt. Virol. Sin. 2017, 32, 476–484. [Google Scholar] [CrossRef] [PubMed]
- Bae, J.Y.; Wu, J.; Lee, H.J.; Jo, E.J.; Murugaiyan, S.; Chung, E.; Lee, S.W. Biocontrol potential of a lytic bacteriophage PE204 against bacterial wilt of tomato. J. Microbiol. Biotechnol. 2012, 22, 1613–1620. [Google Scholar] [CrossRef] [PubMed]
- McKenna, F.; El-Tarabily, K.A.; Hardy, G.E.S.J.; Dell, B. Novel in vivo use of a polyvalent Streptomyces phage to disinfest Streptomyces scabies-infected seed potatoes. Plant Path 2001, 50, 666–675. [Google Scholar] [CrossRef]
- Sieiro, C.; Areal-Hermida, L.; Pichardo-Gallardo, Á.; Almuiña-González, R.; de Miguel, T.; Sánchez, S.; Sánchez-Pérez, Á.; Villa, T.G. A Hundred Years of Bacteriophages: Can Phages Replace Antibiotics in Agriculture and Aquaculture? Antibiotics 2020, 9. [Google Scholar] [CrossRef] [PubMed]
- Inc, O. Agriphage. Available online: https://www.agriphage.com/ (accessed on 22 November 2020).
- Certis USA. Leading Biopesticides. Available online: https://www.certisusa.com/ (accessed on 26 November 2020).
- Nakai, T.; Park, S.C. Bacteriophage therapy of infectious diseases in aquaculture. Res. Microbiol. 2002, 153, 13–18. [Google Scholar] [CrossRef]
- Pridgeon, J. Major bacterial diseases in aquaculture and their vaccine development. CAB Rev. 2012, 7. [Google Scholar] [CrossRef] [Green Version]
- Matamp, N.; Bhat, S.G. Phage Endolysins as Potential Antimicrobials against Multidrug Resistant Vibrio alginolyticus and Vibrio parahaemolyticus: Current Status of Research and Challenges Ahead. Microorganisms 2019, 7. [Google Scholar] [CrossRef] [Green Version]
- Nikapitiya, C.; Chandrarathna, H.; Dananjaya, S.H.S.; De Zoysa, M.; Lee, J. Isolation and characterization of phage (ETP-1) specific to multidrug resistant pathogenic Edwardsiella tarda and its in vivo biocontrol efficacy in zebrafish (Danio rerio). Biologicals 2020, 63, 14–23. [Google Scholar] [CrossRef]
- Karunasagar, I.; Shivu, M.M.; Girisha, S.K.; Krohne, G.; Karunasagar, I. Biocontrol of pathogens in shrimp hatcheries using bacteriophages. Aquaculture 2007, 268, 288–292. [Google Scholar] [CrossRef]
- Matamp, N.; Bhat, S.G. Genome characterization of novel lytic Myoviridae bacteriophage ϕVP-1 enhances its applicability against MDR-biofilm-forming Vibrio parahaemolyticus. Arch. Virol. 2020, 165, 387–396. [Google Scholar] [CrossRef]
- Katharios, P.; Kalatzis, P.G.; Kokkari, C.; Sarropoulou, E.; Middelboe, M. Isolation and characterization of a N4-like lytic bacteriophage infecting Vibrio splendidus, a pathogen of fish and bivalves. PLoS ONE 2017, 12, e0190083. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, L.; Fan, J.; Yan, T.; Liu, Q.; Yuan, S.; Zhang, H.; Yang, J.; Deng, D.; Huang, S.; Ma, Y. Isolation and Characterization of Specific Phages to Prepare a Cocktail Preventing Vibrio sp. Va-F3 Infections in Shrimp (Litopenaeus vannamei). Front. Microbiol. 2019, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Akmal, M.; Rahimi-Midani, A.; Hafeez-Ur-Rehman, M.; Hussain, A.; Choi, T.J. Isolation, Characterization, and Application of a Bacteriophage Infecting the Fish Pathogen Aeromonas hydrophila. Pathogens 2020, 9. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, J.H.; Choresca, C.H.; Shin, S.P.; Han, J.E.; Jun, J.W.; Park, S.C. Biological control of Aeromonas salmonicida subsp. salmonicida infection in rainbow trout (Oncorhynchus mykiss) using Aeromonas phage PAS-1. Transbound. Emerg. Dis. 2015, 62, 81–86. [Google Scholar] [CrossRef] [PubMed]
- Ramírez-Castillo, F.Y.; Loera-Muro, A.; Jacques, M.; Garneau, P.; Avelar-González, F.J.; Harel, J.; Guerrero-Barrera, A.L. Waterborne pathogens: Detection methods and challenges. Pathogens 2015, 4, 307–334. [Google Scholar] [CrossRef] [PubMed]
- Jassim, S.A.; Limoges, R.G.; El-Cheikh, H. Bacteriophage biocontrol in wastewater treatment. World J. Microbiol. Biotechnol. 2016, 32, 70. [Google Scholar] [CrossRef] [PubMed]
- Withey, S.; Cartmell, E.; Avery, L.M.; Stephenson, T. Bacteriophages—Potential for application in wastewater treatment processes. Sci. Total. Environ. 2005, 339, 1–18. [Google Scholar] [CrossRef] [Green Version]
- Pal, P.; Khairnar, K. Causes and remedies for filamentous foaming in activated sludge treatment plant. Global Nest J. 2014, 16, 762–772. [Google Scholar] [CrossRef]
- Khairnar, K.; Pal, P.; Chandekar, R.H.; Paunikar, W.N. Isolation and characterization of bacteriophages infecting nocardioforms in wastewater treatment plant. Biotech. Res. Int. 2014, 2014, 151952. [Google Scholar] [CrossRef] [Green Version]
- Kramer, A.; Schwebke, I.; Kampf, G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect. Dis. 2006, 6, 130. [Google Scholar] [CrossRef] [Green Version]
- Allegranzi, B.; Bagheri Nejad, S.; Combescure, C.; Graafmans, W.; Attar, H.; Donaldson, L.; Pittet, D. Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis. Lancet 2011, 377, 228–241. [Google Scholar] [CrossRef]
- Otter, J.A.; Yezli, S.; French, G.L. The Role Played by Contaminated Surfaces in the Transmission of Nosocomial Pathogens. Infect. Cont. Hosp. Ep. 2011, 32, 687–699. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Otter, J.A.; Yezli, S.; Salkeld, J.A.G.; French, G.L. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am. J. Infect. Control 2013, 41, S6–S11. [Google Scholar] [CrossRef] [PubMed]
- Maurice, N.M.; Bedi, B.; Sadikot, R.T. Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections. Am. J. Resp. Cell Mol. Biol. 2018, 58, 428–439. [Google Scholar] [CrossRef]
- Pachori, P.; Gothalwal, R.; Gandhi, P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; A critical review. Genes Dis. 2019, 6, 109–119. [Google Scholar] [CrossRef]
- DeLeo, F.R.; Chambers, H.F. Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J. Clin. Invest. 2009, 119, 2464–2474. [Google Scholar] [CrossRef] [Green Version]
- Larramendy, S.; Deglaire, V.; Dusollier, P.; Fournier, J.P.; Caillon, J.; Beaudeau, F.; Moret, L. Risk Factors of Extended-Spectrum Beta-Lactamases-Producing Escherichia coli Community Acquired Urinary Tract Infections: A Systematic Review. Infect. Drug Resist. 2020, 13, 3945–3955. [Google Scholar] [CrossRef]
- Caselli, E.; D’Accolti, M.; Vandini, A.; Lanzoni, L.; Camerada, M.T.; Coccagna, M.; Branchini, A.; Antonioli, P.; Balboni, P.G.; Di Luca, D.; et al. Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation. PLoS ONE 2016, 11, e0148857. [Google Scholar] [CrossRef] [Green Version]
- Chen, L.K.; Liu, Y.L.; Hu, A.R.; Chang, K.C.; Lin, N.T.; Lai, M.J.; Tseng, C.C. Potential of bacteriophage phi AB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. BMC Microbiol. 2013, 13. [Google Scholar] [CrossRef] [Green Version]
- Jensen, K.C.; Hair, B.B.; Wienclaw, T.M.; Murdock, M.H.; Hatch, J.B.; Trent, A.T.; White, T.D.; Haskell, K.J.; Berges, B.K. Isolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite Decontaminant. PLoS ONE 2015, 10. [Google Scholar] [CrossRef]
- D’Accolti, M.; Soffritti, I.; Piffanelli, M.; Bisi, M.; Mazzacane, S.; Caselli, E. Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: Potential as sanitizing agents. Infect. Drug Resist. 2018, 11, 1015–1026. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- D’Accolti, M.; Soffritti, I.; Lanzoni, L.; Bisi, M.; Volta, A.; Mazzacane, S.; Caselli, E. Effective elimination of Staphylococcal contamination from hospital surfaces by a bacteriophage-probiotic sanitation strategy: A monocentric study. Microb. Biotech. 2019, 12, 742–751. [Google Scholar] [CrossRef] [Green Version]
- Caselli, E.; Arnoldo, L.; Rognoni, C.; D’Accolti, M.; Soffritti, I.; Lanzoni, L.; Bisi, M.; Volta, A.; Tarricone, R.; Brusaferro, S.; et al. Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: A multicenter study. Infect. Drug Resist. 2019, 12, 501–510. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Caselli, E.; Brusaferro, S.; Coccagna, M.; Arnoldo, L.; Berloco, F.; Antonioli, P.; Tarricone, R.; Pelissero, G.; Nola, S.; La Fauci, V.; et al. Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study. PLoS ONE 2018, 13, e0199616. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Caselli, E.; D’Accolti, M.; Soffritti, I.; Lanzoni, L.; Bisi, M.; Volta, A.; Berloco, F.; Mazzacane, S. An Innovative Strategy for the Effective Reduction of MDR Pathogens from the Nosocomial Environment. Adv. Exp. Med. Biol. 2019. [Google Scholar] [CrossRef]
- Caselli, E.; Berloco, F. Influence of Sanitizing Methods on Healthcare-Associated Infections Onset: A Multicentre, Randomized, Controlled Pre-Post Interventional Study. J. Clin. Trials 2016, 6. [Google Scholar] [CrossRef]
- D’Accolti, M.; Soffritti, I.; Mazzacane, S.; Caselli, E. Fighting AMR in the Healthcare Environment: Microbiome-Based Sanitation Approaches and Monitoring Tools. Inter. J. Mol. Sci. 2019, 20. [Google Scholar] [CrossRef] [Green Version]
- Caselli, E.; Antonioli, P.; Mazzacane, S. Safety of probiotics used for hospital environmental sanitation. J. Hosp. Infect. 2016, 94, 193–194. [Google Scholar] [CrossRef]
- Huang, S.S.; Datta, R.; Platt, R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch. Intern. Med. 2006, 166, 1945–1951. [Google Scholar] [CrossRef] [Green Version]
- Bock, L.J.; Wand, M.E.; Sutton, J.M. Varying activity of chlorhexidine-based disinfectants against Klebsiella pneumoniae clinical isolates and adapted strains. J. Hosp. Infect. 2016, 93, 42–48. [Google Scholar] [CrossRef]
- Oechslin, F. Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy. Viruses 2018, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
D’Accolti, M.; Soffritti, I.; Mazzacane, S.; Caselli, E. Bacteriophages as a Potential 360-Degree Pathogen Control Strategy. Microorganisms 2021, 9, 261. https://doi.org/10.3390/microorganisms9020261
D’Accolti M, Soffritti I, Mazzacane S, Caselli E. Bacteriophages as a Potential 360-Degree Pathogen Control Strategy. Microorganisms. 2021; 9(2):261. https://doi.org/10.3390/microorganisms9020261
Chicago/Turabian StyleD’Accolti, Maria, Irene Soffritti, Sante Mazzacane, and Elisabetta Caselli. 2021. "Bacteriophages as a Potential 360-Degree Pathogen Control Strategy" Microorganisms 9, no. 2: 261. https://doi.org/10.3390/microorganisms9020261
APA StyleD’Accolti, M., Soffritti, I., Mazzacane, S., & Caselli, E. (2021). Bacteriophages as a Potential 360-Degree Pathogen Control Strategy. Microorganisms, 9(2), 261. https://doi.org/10.3390/microorganisms9020261